Under the liquidity contract entrusted by Innate Pharma to Natixis Securities, the following assets appeared on the liquidity account as at December 31, 2010:
• 133,129 shares of Innate Pharma, and
• 10,378.28 euros in cash
| PR in English | 34.19 KB |
| CP en français | 33.93 KB |